Wealth Bridge Capital Management, LLC Geron Corp Transaction History

Wealth Bridge Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$1.37 - $2.02 $685 - $1,010	-500 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$1.01 - $1.83 $303 - $549	-300 Reduced 37.5%	500 $1,000
Q4 2018 Feb 14, 2019	BUY	$0.98 - $1.85 $784 - $1,480	800 New	800 $1,000

259

450M

1.91M

897K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.59B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Wealth Bridge Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Bridge Capital Management, LLC with notifications on news.